These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1198462)

  • 1. Proceedings: Electron microscopic studies of fibrinogen degradation products.
    Marder VJ; Budzynski AZ; Tranqui-Pouit L; Suscillon M; Hudry-Clergeon G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):572. PubMed ID: 1198462
    [No Abstract]   [Full Text] [Related]  

  • 2. [alphaC domains of fibrinogen molecules as the structures accelerating fibrin assembly].
    Medved' LV; Gorkun OV; Maniakov VF; Belitser VA
    Mol Biol (Mosk); 1986; 20(2):461-70. PubMed ID: 3702870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of DL and DH degradation products in the reactions of the plasmin hydrolysis of fibrinogen and fibrin].
    Rozenfel'd MA; Leonova VB; Khavkina LS
    Izv Akad Nauk SSSR Biol; 1991; (3):334-42. PubMed ID: 1835465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proceedings: Electron microscopic studies of the molecular shape of fibrinogen molecule.
    Tranqui L; Marder VL; Suscillon M; Budzynski AZ; Hudry G
    Thromb Diath Haemorrh; 1975 Nov; 34(2):571-2. PubMed ID: 1198461
    [No Abstract]   [Full Text] [Related]  

  • 5. Structural considerations of plasmic degradation of fibrinogen.
    Marder VJ; Budzynski AZ
    Pathol Biol (Paris); 1974 Nov; 22 suppl():43-6. PubMed ID: 4283397
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Structural studies of fibrinogen by ultrasound irradiation.
    Albert A; Ayuso MR; Usobiaga P
    Thromb Diath Haemorrh; 1975 Nov; 34(2):573. PubMed ID: 1198466
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Quantitative determination of fibrinogen-fibrin degradation products by viro-immunoassay.
    Lederman S; Rimon A
    Isr J Med Sci; 1975 Dec; 11(12):1395. PubMed ID: 1218992
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: Fibrinogen/fibrin degradation products in defibrination syndrome analysed on the basis of molecular weight on gel exclusion chromatography.
    Kazama M; Abe T
    Thromb Diath Haemorrh; 1975 Sep; 34(1):339-40. PubMed ID: 1188772
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical evaluation of new methods for studying fibrin degradation products].
    Prisco D
    Recenti Prog Med; 1989 May; 80(5):263-7. PubMed ID: 2669062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intrinsic fluorescence of human fibrinogen and its fragments D and E.
    Kowalska MA; Cierniewski CS
    Thromb Haemost; 1982 Aug; 48(1):21-3. PubMed ID: 7135341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possibilities of using immunoenzyme test systems for determining levels of myoglobin, fibrinogen, fibrin-fibrinogen degradation products and fibronectin in the diagnosis of somatic diseases].
    Ermolin GA; Shelepova TM; Dikov MM; Osmanov SK; Voloshchuk OM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(1):33-7. PubMed ID: 3300700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products].
    Dyr JE; Cajthamlová H; Suttnar J
    Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of fragments D and double-D from fibrinogen and fibrin.
    Doolittle RF; Spraggon G; Everse SJ
    Thromb Haemost; 1999 Aug; 82(2):271-6. PubMed ID: 10605713
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrinogen degradation products in fresh frozen plasma. Possible contribution to immunosuppression.
    Donnell CA; Daniel SJ; Ferrara JJ
    Am Surg; 1989 Aug; 55(8):505-7. PubMed ID: 2764399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 17. A quantitative enzyme immunoassay for primary fibrinogenolysis products in plasma.
    Koppert PW; Kuipers W; Hoegee-de Nobel B; Brommer EJ; Koopman J; Nieuwenhuizen W
    Thromb Haemost; 1987 Feb; 57(1):25-8. PubMed ID: 2438796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Terminology for macromolecular plasmic derivatives of crosslinked fibrin.
    Francis CW; Alkjaersig N; Galanakis DK; Graeff H; Owen J; Gaffney P; Marder VJ
    Thromb Haemost; 1987 Feb; 57(1):110-1. PubMed ID: 2954259
    [No Abstract]   [Full Text] [Related]  

  • 19. [Fibrinogen/fibrin degradation products in the toxemic patient].
    Ahued Ahued JR; Gaviño Ambriz S; Gaviño Gaviño F; Terán Ortiz LM
    Ginecol Obstet Mex; 1985 Apr; 53(336):83-6. PubMed ID: 4029682
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen-fibrin degradation products.
    Kwaan HC
    Ann Clin Lab Sci; 1980; 10(3):234-7. PubMed ID: 7396389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.